10-K
Annual Report
ALTO INGREDIENTS, INC.
ALTO
NASDAQ
CIK: 778164
File #: 000-21467
Balance Sheet
54 line items · 2 periods
XBRL
| Item | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|
ASSETS | ||
Current Assets: | ||
Cash and cash equivalents | 30,014,000 | 36,456,000 |
Restricted cash | 15,466,000 | 13,069,000 |
Cash Collateral Balance | 15,466,000 | 13,069,000 |
Accounts receivable, net of allowance for credit losses of $85 and $105, respectively | 58,729,000 | 68,655,000 |
Inventories | 52,611,000 | 66,628,000 |
Inventories | 41,041,000 | 43,484,000 |
Derivative instruments | 2,412,000 | 4,973,000 |
Commodity Contract | 2,412,000 | 4,973,000 |
Derivative Financial Instruments, Assets | 2,412,000 | 4,973,000 |
Derivative Financial Instruments, Assets - Level 1 | 2,412,000 | 4,973,000 |
Other current assets | 9,538,000 | 9,340,000 |
Total current assets | 168,770,000 | 199,121,000 |
Property and equipment, net | 248,748,000 | 239,069,000 |
Other Assets: | ||
Right of use operating lease assets, net | 22,597,000 | 18,937,000 |
Intangible assets, net | 8,498,000 | 9,087,000 |
Goodwill | — | 5,970,000 |
Other assets | 5,628,000 | 6,137,000 |
Total other assets | 36,723,000 | 40,131,000 |
Total Assets | 454,241,000 | 478,321,000 |
Pekin Campus production | 251,048,000 | 257,089,000 |
Marketing and distribution | 101,196,000 | 114,755,000 |
Other production | 57,533,000 | 51,886,000 |
Corporate and Other | 44,464,000 | 54,591,000 |
Current Liabilities: | ||
Accounts payable | 20,752,000 | 28,115,000 |
Accrued liabilities | 20,205,000 | 26,556,000 |
Current portion – operating leases | 4,333,000 | 3,849,000 |
Derivative instruments | 13,849,000 | 6,732,000 |
Commodity Contract | 13,849,000 | 6,732,000 |
Derivative Financial Instruments, Liabilities | 13,849,000 | 6,732,000 |
Derivative Financial Instruments, Liabilities - Level 1 | 13,849,000 | 6,732,000 |
Other current liabilities | 6,149,000 | 12,765,000 |
Acquisition of Eagle Alcohol | 2,800,000 | 3,500,000 |
Total current liabilities | 65,288,000 | 78,017,000 |
Long-term debt, net | 82,097,000 | 68,356,000 |
Operating leases, net of current portion | 19,029,000 | 15,062,000 |
Other liabilities | 8,270,000 | 8,797,000 |
Total Liabilities | 174,684,000 | 170,232,000 |
Stockholders’ Equity: | ||
Series B Preferred Stock | 1,000 | 1,000 |
Common stock, value | 76,000 | 75,000 |
Additional paid-in capital | 1,040,912,000 | 1,040,834,000 |
Accumulated other comprehensive income | 2,481,000 | 1,822,000 |
Accumulated deficit | (763,913,000) | (734,643,000) |
Total stockholders’ equity | 279,557,000 | 308,089,000 |
Preferred Stock | 1,000 | 1,000 |
Common Stock and Non-Voting Common Shares | 76,000 | 75,000 |
Additional Paid-In Capital | 1,040,912,000 | 1,040,834,000 |
Accumulated Deficit | (763,913,000) | (734,643,000) |
Accum. Other Comprehensive Income (Loss) | 2,481,000 | 1,822,000 |
Total Liabilities and Stockholders’ Equity | 454,241,000 | 478,321,000 |